Envestnet Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.2M | Buy |
|
|||||
|
2025
Q1 | $19.5M | Buy |
|
|||||
|
2024
Q4 | $15.5M | Buy |
|
|||||
|
2024
Q3 | $8.63M | Buy |
|
|||||
|
2024
Q2 | $6.11M | Sell |
|
|||||
|
2024
Q1 | $4.1M | Buy |
|
|||||
|
2023
Q4 | $5.22M | Buy |
|
|||||
|
2023
Q3 | $4.35M | Buy |
|
|||||
|
2023
Q2 | $3.58M | Buy |
|
|||||
|
2023
Q1 | $3.08M | Buy |
|
|||||
|
2022
Q4 | $3.35M | Sell |
|
|||||
|
2022
Q3 | $3.42M | Buy |
|
|||||
|
2022
Q2 | $2.06M | Sell |
|
|||||
|
2022
Q1 | $5.13M | Sell |
|
|||||
|
2021
Q4 | $5.82M | Buy |
|
|||||
|
2021
Q3 | $5.94M | Buy |
|
|||||
|
2021
Q2 | $5.09M | Buy |
|
|||||
|
2021
Q1 | $3.76M | Buy |
|
|||||
|
2020
Q4 | $1.77M | Sell |
|
|||||
|
2020
Q3 | $5.62M | Sell |
|
|||||
|
2020
Q2 | $5.97M | Buy |
|
|||||
|
2020
Q1 | $914K | Buy |
|